Global Gastroparesis Treatment Market Growth (Status and Outlook) 2023-2029

Global Gastroparesis Treatment Market Growth (Status and Outlook) 2023-2029

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

LPI (LP Information)' newest research report, the “Gastroparesis Treatment Industry Forecast” looks at past sales and reviews total world Gastroparesis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastroparesis Treatment sales for 2023 through 2029. With Gastroparesis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastroparesis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Gastroparesis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastroparesis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastroparesis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastroparesis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastroparesis Treatment.

The global Gastroparesis Treatment market size is projected to grow from US$ 5535.9 million in 2022 to US$ 6957.7 million in 2029; it is expected to grow at a CAGR of 3.3% from 2023 to 2029.

North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.

Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastroparesis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Drug Treatment
Surgical Treatment

Segmentation by application
Hospital
Ambulatory Surgical Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott
Bausch Health
Boston Scientific
C.R. Bard
Johnson & Johnson
Cardinal Health
Evoke Pharma
Rhythm Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.